knowledge -WSS

knowledge

author：explore 2025-09-30 20:27:08 - browse：571

Geoff Martha, CEO of Medtronic Courtesy Medtronic

As one of the largest and oldest medical device companies in the world, Medtronic has a foot in almost every clinical area.

The device maker with a market valuation of nearly $100 billion sells pacemakers, spinal cord stimulators, stents, monitors. Name a device, and they probably make it. The behemoth is ubiquitous in health care, but its size can make innovation sluggish. Medtronic has tried to become more streamlined in recent years — the company announced plans last year to spin off its patient monitoring and respiratory businesses, which Reuters recently reported, citing unnamed sources, may go to the Carlyle Group, a private equity firm.

Still, the device giant is immersed in many different specialties, including diabetes and high blood pressure, where the company has experienced some setbacks. Medtronic has sold old-school insulin pumps since the 1980s and therefore developed robust dosing algorithms, but has never successfully built a tubeless pump. The company plans to buy Korean patch pump maker EOFlow, but EOFlow is enmeshed in a patent battle with Insulet. A federal judge blocked EOFlow from selling its wearable patch pumps earlier this month.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Readout Newsletter: Zepbound, Valneva's vaccine, and more

WSS

Cuban government calls US nuclear submarine stop a 'provocative escalation'

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

First transplant of an entire human eye performed

Sickle cell gene therapy cures need to be accessible in Africa

A letter from the executive editor: STAT UnitedHealth investigation

Ventyx halts psoriasis drug development after lackluster trial results

explore

knowledge

hotspot

Peter Hotez and the public health issue of online harassment

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Medicare details structure of new drug price negotiation program

UnitedHealth sued over use of algorithm in Medicare Advantage plans

Activists slam private health insurers over coverage restrictions

Type 2 diabetes prevention programs work at large scale: study

In age of alternative facts, a scholarly course on calling out crap

Carbon Health diabetes program, a test of data

Drug repurposing or repositioning? The language matters

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

entertainment

What is STAT's opinion section for?

What is STAT's opinion section for?

What health policies could hitch a ride on a spending bill?

A Greenpeace activist is fined for crash

After decades in use, heart stents finally beat placebo

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

hotspot

entertainment

focus

explore